EbookBell.com

Most ebook files are in PDF format, so you can easily read them using various software such as Foxit Reader or directly on the Google Chrome browser.
Some ebook files are released by publishers in other formats such as .awz, .mobi, .epub, .fb2, etc. You may need to install specific software to read these formats on mobile/PC, such as Calibre.

Please read the tutorial at this link: https://ebookbell.com/faq

We offer FREE conversion to the popular formats you request; however, this may take some time. Therefore, right after payment, please email us, and we will try to provide the service as quickly as possible.

For some exceptional file formats or broken links (if any), please refrain from opening any disputes. Instead, email us first, and we will try to assist within a maximum of 6 hours.

EbookBell Team

Biosimilars For Cancer Treatment A Promising Approach Shvetank Bhatt

Name: Biosimilars For Cancer Treatment A Promising Approach Shvetank Bhatt
SKU: BELL-58314234
Price: 31.00 USD
Availability: InStock
Rating: 4.7 (26 reviews)

SKU: BELL-58314234

$ 31.00 ~~$ 45.00~~ (-31%)

4.7

26 reviews

Biosimilars For Cancer Treatment A Promising Approach Shvetank Bhatt instant download after payment.

Publisher: Springer

File Extension: PDF

File size: 5.76 MB

Pages: 325

Author: Shvetank Bhatt, Harish Dureja, Samir Gunvantbhai Patel, Archita Samir Patel, Kamal Dua

ISBN: 9789819730001, 9819730007

Language: English

Year: 2024

Product desciption

Biosimilars For Cancer Treatment A Promising Approach Shvetank Bhatt by Shvetank Bhatt, Harish Dureja, Samir Gunvantbhai Patel, Archita Samir Patel, Kamal Dua 9789819730001, 9819730007 instant download after payment.

The book delves into the role of biosimilars in the field of cancer treatment. It also discusses the application of biosimilars in various cancer types, from colorectal and cervical to prostate, gastric, lung, pancreatic, breast, hepatocellular, ovarian, and blood cancers. It contains chapters that focus on the clinical trials of biosimilars, providing insights into the latest research and developments. This book serves as a valuable resource for clinicians, researchers, and anyone seeking a comprehensive understanding of the intersection between biosimilars and cancer treatment.